Major depressive disorder (MDD) is a chronic and recurrent ... of such MDD patients remit following adequate antidepressant treatment, while most MDD patients suffer from significant core ...

For the twenty-one million American adults experiencing major depressive disorder (MDD) annually, this FDA-cleared treatment ...

Relmada is now scrapping Reliance II, plus another phase 3 trial called Relight, which was assessing REL-1017 as an add-on ...

The CDC estimates that depression now impacts one in six American adults. After the newest numbers, ABC15 gets an up close ...

Spruce Biosciences discontinues tildacerfont trials for CAH as CAHmelia-204 misses primary endpoint and CAHptain-205 shows ...

In the U.S. women are far more likely than men to seek treatment for depression ... The so-called burden of depression is great, as the disorder is a major cause of missed work and poor ...

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry ...

The wish to die is usually transient, or at least time-limited and reversible. Having a support system with an explicit plan ...

The differential diagnosis among these and with regard to other disorders with similar symptom features remains the foundation for treatment ... depressive symptoms without manic, mixed, or major ...